Suvretta Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Suvretta Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-37,111	Closed	-$1.29M	–	97
2025 Q3	$1.29M	Hold	37,111	–	–	0.03%	82
2025 Q2	$1.04M	Hold	37,111	–	–	0.03%	81
2025 Q1	$932K	Hold	37,111	–	–	0.03%	91
2024 Q4	$1.02M	Sell	37,111 -10,089	-21%	-$281K	0.03%	84
2024 Q3	$1.36M	Hold	47,200	–	–	0.04%	80
2024 Q2	$1.17M	Hold	47,200	–	–	0.04%	75
2024 Q1	$1.52M	Hold	47,200	–	–	0.06%	81
2023 Q4	$1.92M	Hold	47,200	–	–	0.09%	64
2023 Q3	$1.63M	Hold	47,200	–	–	0.09%	69
2023 Q2	$1.92M	Hold	47,200	–	–	0.1%	75
2023 Q1	$1.82M	Hold	47,200	–	–	0.08%	71
2022 Q4	$2.09M	Buy	+47,200	New	+$1.99M	0.09%	63

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Suvretta Capital Management's LKFT Position: Q4 2025 in Review

Suvretta Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2025, closing a stake of 37,111 shares — an estimated $1.29M sold.

Suvretta Capital Management first reported a position in LKFT in Q4 2022 and held it in 12 quarters. The position peaked at $2.09M in Q4 2022. 90 funds tracked by Wall St. Rank hold LKFT as of Q4 2025.

Suvretta Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2025 after selling out during the quarter.
Suvretta Capital Management sold 37,111 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2025, an estimated $1.29M.
Suvretta Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2022 and held it in 12 quarters.
Suvretta Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.09M in Q4 2022.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2025.

Based on Suvretta Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.